DR. NABIL M AHMED, MD
Medical Practice at Fannin St, Houston, TX
License number
Texas M5014
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
6701 Fannin St, Houston, TX 77030
Phone
(832) 822-4890
(713) 798-1750
(713) 798-1144 (Fax)
(713) 798-1750
(713) 798-1144 (Fax)
Personal information
See more information about NABIL M AHMED at radaris.comName
Address
Phone
3414 Norris Dr, Houston, TX 77025
Houston, TX
Professional information
See more information about NABIL M AHMED at trustoria.com
Dr. Nabil M Ahmed, Houston TX - MD (Doctor of Medicine)
Dr. Nabil M Ahmed, Houston TX - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
6701 Fannin St, Houston 77030
(832) 822-4890 (Phone)
(832) 822-4890 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2006, Pediatrics, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
6701 Fannin St, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Education:
Medical School
University Of Cairo, Faculty Of Medicine
University Of Cairo, Faculty Of Medicine
Nabil M Ahmed, Houston TX
Nabil M Ahmed, Houston TX
Specialties:
Pediatric Hematologist / Oncologist
Address:
6701 Fannin St, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
Education:
Bachelor of Medicine, Bachelor of Surgery
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Nabil Mohamed Ahmed M.Sc, Houston TX
Nabil Mohamed Ahmed M.Sc, Houston TX
Specialties:
Pediatrics, Pediatric Hematology-Oncology, Hematology, Hematology & Oncology, Medical Oncology
Work:
Texas Childrens Cancer Center And Hematology Service Clinica
6701 Fannin St, Houston, TX 77030
6701 Fannin St, Houston, TX 77030
Education:
University Of Cairo (1995)
Chimeric Antigen Receptor For Bispecific Activation And Targeting Of T Lymphocytes
Chimeric Antigen Receptor For Bispecific Activation And Targeting Of T Lymphocytes
US Patent:
2013028, Oct 24, 2013
Filed:
Mar 7, 2013
Appl. No.:
13/788267
Inventors:
Nabil Ahmed - Houston TX, US
Zakaria Grada - Houston TX, US
Meenakshi Hedge - Houston TX, US
Matthew Baker - Bellaire TX, US
Donald R. Shaffer - Houston TX, US
Zakaria Grada - Houston TX, US
Meenakshi Hedge - Houston TX, US
Matthew Baker - Bellaire TX, US
Donald R. Shaffer - Houston TX, US
International Classification:
C12N 15/85, A61K 45/06, A61K 35/14
US Classification:
424 9321, 435325, 4353201, 435455
Abstract:
Embodiments of the invention include methods and compositions related to improved cells encoding a chimeric antigen receptor that is specific for two or more antigens. In certain aspects the receptor encompasses two or more non-identical antigen recognition domains. The antigens are tumor antigens, in particular embodiments.
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
US Patent:
2014000, Jan 2, 2014
Filed:
Sep 8, 2011
Appl. No.:
13/820931
Inventors:
Malcolm Brenner - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
International Classification:
C12N 5/0783, C07K 16/18
US Classification:
4241781, 424 9321, 435375
Abstract:
The present invention concerns immunotherapy for cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed. In particular cases, the chimeric receptor comprises antibody, cytoplasmic signaling domain from the T cell receptor, and/or costimulatory molecule(s).